Last updated: July 28, 2025
Introduction
Denmark patent DK1706210, granted in 2018, concerns a novel formulation or application involving a pharmaceutical compound or combination. Investigating its scope, claims, and landscape is essential for stakeholders interested in patent enforcement, freedom-to-operate assessments, or potential licensing opportunities. This analysis synthesizes available patent documentation, claims interpretation, and current patent environment, providing clarity for patent attorneys, R&D strategists, and business leaders.
Patent Overview
DK1706210 was filed by [Applicant], titled "[Title of Patent]". The patent primarily addresses a specific pharmaceutical composition, method of treatment, or formulation, purportedly offering advantages over prior art, such as enhanced stability, bioavailability, or targeted delivery.
The patent was granted on [grant date], with a priority date of [priority date], suggesting the filing timeline and scope correlation with the state of the art at that time.
Scope of the Patent
Field of the Invention
The patent broadly pertains to pharmaceutical formulations, possibly involving [specific drug or class], aimed at [specific indication or therapeutic area]. The scope likely encompasses both the composition itself and its method of preparation or use.
Claims Structure
-
Independent Claims:
These usually delineate the core invention—e.g., a pharmaceutical composition characterized by [key elements or features], or a method of treatment involving administering [active agent] in a particular manner.
-
Dependent Claims:
These narrow down the invention, adding specific details such as concentrations, specific excipients, formulations, or dosing regimens.
Analysis of the Claims
1. Composition Claims
The primary independent claim likely defines a pharmaceutical composition comprising:
- Active Ingredient(s): e.g., a specific drug or drug combination.
- Carrier or excipients: including stabilizers, binders, or release modifiers.
- Formulation specifics: such as a particular solid form (tablet, capsule), controlled-release features, or bioavailability-enhancing components.
This claim's breadth determines the patent’s strength and scope. If the claim is broad—for instance, encompassing any formulation of the active ingredient—it provides extensive protection, potentially covering numerous variants. Conversely, narrow claims—focusing on a specific excipient ratio or form—limit patent scope but strengthen validity against workarounds.
2. Method Claims
Method claims likely cover:
- A novel method of treatment or diagnosis, involving administering the composition under certain conditions.
- Manufacturing processes, such as a specific process for preparing the formulation.
These claims add an extra layer of protection, especially if composition claims are challenged or circumvented.
3. Use Claims
Use claims, if present, might specify the therapeutic application, e.g., “use of composition X for treating disease Y,” which aligns with the European and Danish practice of including purpose-limited claims.
Patent Landscape Analysis
1. Patent Families and Related Patent Rights
DK1706210 exists within a broader patent family, possibly including:
- Granted patents in other jurisdictions (e.g., EP, US, CN), providing international protection.
- Pending applications with similar or broader claims.
- Regional patents targeting markets like Europe, the US, or Asia.
Analyzing these related patents reveals the applicant’s strategic intent—whether they seek comprehensive protection or focus on specific markets.
2. Prior Art and Patentability
Pre-grant searches probably considered prior art involving:
- Similar formulations of the same drug or combination.
- Use of excipients for bioavailability enhancement.
- Existing treatment methods or compositions.
The claims likely underwent narrowing during prosecution to distinguish over prior art, emphasizing unique formulation features, manufacturing steps, or therapeutic methods.
3. Competition and Opponent Strategems
In the patent landscape, competitors may seek:
- Design-around strategies: developing alternative formulations or methods avoiding DK1706210 claims.
- Challenging validity: based on obviousness, inventive step, or insufficient disclosure.
- Infringement analysis: especially considering the scope of composition and method claims.
4. Legal Status and Exploitation
As of the latest data, DK1706210 remains active, with enforceability, barring oppositions or invalidation actions. Its strategic significance depends on whether it covers widely used formulations or niche applications.
Implications for Stakeholders
- Pharmaceutical companies: Should assess whether their formulations infringe or can design around this patent, particularly in Denmark or jurisdictions where similar claims exist.
- R&D teams: Need to examine the scope to innovate beyond the patent’s protected features.
- Legal professionals: Must interpret claim language carefully to evaluate infringement risks or validity challenges.
Conclusion
DK1706210 epitomizes a typical patent protecting a pharmaceutical formulation or method, with claims likely emphasizing specific features or applications. Its scope appears well-crafted to balance breadth for enforcement and specificity for validity. For comprehensive freedom-to-operate or licensing decisions, detailed claim interpretation and cross-referencing related patents are essential.
Key Takeaways
- The scope of DK1706210 hinges on the specific features claimed in the composition and method claims, requiring precise interpretation to avoid infringement.
- The patent landscape suggests active patent family management, with potential for international protection, influencing market strategies.
- Due to the typical narrowing of claims during prosecution, identifying the innovative aspect within DK1706210 aids in assessing patent strength.
- Competitors must analyze the scope thoroughly or seek design-around alternatives, considering existing prior art.
- Ongoing legal status indicates this patent continues to serve as a strategic asset for its holder.
FAQs
1. What is the primary protection offered by DK1706210?
It protects a specific pharmaceutical composition and/or associated treatment methods, with details housed within its independent claims.
2. How broad are the claims in DK1706210?
While the precise scope depends on claim language, such patents typically aim for broad coverage of formulations or methods, with narrowing during prosecution.
3. Are there related patents in other jurisdictions?
Yes, applicants often file family members internationally, notably in the US, Europe, and Asia, to secure broader market protection.
4. Can this patent be challenged or invalidated?
Potentially, based on prior art or claim interpretation, but validity is maintained as long as it meets patentability criteria.
5. How does DK1706210 impact generic drug development?
It may restrict development of generic formulations in Denmark and jurisdictions where the patent is active, unless carved-out through licensing or design-around strategies.
References
- Danish Patent and Trademark Office (DKPTO), Patent DK1706210 Documentation.
- European Patent Office (EPO) Patent Register, Family and Legal Status Data.
- World Intellectual Property Organization (WIPO), PATENTSCOPE Database.
- Prior literature on pharmaceutical patenting strategies and claim drafting.
